Bristol Myers Sells 60% Holding in China Partnership Deal
Bristol Myers Squibb has taken another significant step in reshaping its global strategy. The company has officially announced the sale of its 60% stake in a long-standing China partnership. This move has attracted the attention of global investors, stock market analysts, and healthcare industry experts who are closely tracking the changing dynamics of pharmaceutical expansion…